Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1394
mi
from 98109
Minneapolis, MN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Minneapolis
1394
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1611
mi
from 98109
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Columbia (Truman Memorial)
1611
mi
from 98109
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1611
mi
from 98109
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Ellis Fischel Cancer Center - Columbia
1611
mi
from 98109
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1612
mi
from 98109
Columbia, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
University of Missouri
1612
mi
from 98109
Columbia, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1717
mi
from 98109
Saint Louis, MO
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Barnes Jewish Hospital
1717
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1366
mi
from 98109
Omaha, NE
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Univ of Nebraska Med Ctr
1366
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
871
mi
from 98109
Las Vegas, NV
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Southern Nevada Cancer Research Foundation
871
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2393
mi
from 98109
Lebanon, NH
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Norris Cotton Cancer Center
2393
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2112
mi
from 98109
Buffalo, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Buffalo
2112
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2414
mi
from 98109
Manhasset, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - North Shore University Hospital
2414
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2414
mi
from 98109
Manhasset, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
North Shore University Hospital
2414
mi
from 98109
Manhasset, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2402
mi
from 98109
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2402
mi
from 98109
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
The New York Presbyterian Hospital - Cornell Campus
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2402
mi
from 98109
New York, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Mount Sinai Medical Center, NY
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2232
mi
from 98109
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C.
2232
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2235
mi
from 98109
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
State University of New York Upstate Medical University
2235
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2233
mi
from 98109
Syracuse, NY
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Syracuse
2233
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2337
mi
from 98109
Chapel Hill, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Lineberger Comprehensive Cancer Center, UNC
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2338
mi
from 98109
Durham, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Durham
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2341
mi
from 98109
Durham, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Duke Comprehensive Cancer Center
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2271
mi
from 98109
Winston-Salem, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
CCOP - Southeast Cancer Control Consortium
2271
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2274
mi
from 98109
Winston-Salem, NC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2006
mi
from 98109
Columbus, OH
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Arthur G. James Cancer Hospital - Ohio State University
2006
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2486
mi
from 98109
Providence, RI
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Rhode Island Hospital
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2422
mi
from 98109
Charleston, SC
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Medical University of South Carolina
2422
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1866
mi
from 98109
Memphis, TN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
University of Tennessee, Memphis Cancer Center
1866
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
1867
mi
from 98109
Memphis, TN
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Memphis
1867
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2389
mi
from 98109
White River Junction, VT
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - White River Junction
2389
mi
from 98109
White River Junction, VT
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2349
mi
from 98109
Richmond, VA
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
Veterans Affairs Medical Center - Richmond
2349
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated:  7/11/2016
2352
mi
from 98109
Richmond, VA
Conventional or Video-Assisted Surgery in Treating Patients With Lung Metastases
Phase III Randomized Prospective Trial of Open Versus Minimally Invasive, Video-Assisted Resection of Pulmonary Metastases
Status: Enrolling
Updated: 7/11/2016
MBCCOP - Massey Cancer Center
2352
mi
from 98109
Richmond, VA
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
2377
mi
from 98109
Basking Ridge, NJ
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering at Basking Ridge
2377
mi
from 98109
Basking Ridge, NJ
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
2431
mi
from 98109
Commack, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Commack
2431
mi
from 98109
Commack, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
2402
mi
from 98109
New York, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
2420
mi
from 98109
Rockville Centre, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan Kettering Cancer Center at Mercy Medical Center
2420
mi
from 98109
Rockville Centre, NY
Click here to add this to my saved trials
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated:  7/11/2016
2397
mi
from 98109
Sleepy Hollow, NY
Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Phase II Study of a Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer
Status: Enrolling
Updated: 7/11/2016
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center
2397
mi
from 98109
Sleepy Hollow, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2432
mi
from 98109
New Haven, CT
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2402
mi
from 98109
Bronx, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2402
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2400
mi
from 98109
New York, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2400
mi
from 98109
New York, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2161
mi
from 98109
Rochester, NY
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2020
mi
from 98109
Cleveland, OH
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
2
mi
from 98109
Seattle, WA
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated:  7/12/2016
7750
mi
from 98109
Camperdown,
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors
Status: Enrolling
Updated: 7/12/2016
7750
mi
from 98109
Camperdown,
Click here to add this to my saved trials
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer
Status: Enrolling
Updated:  7/12/2016
1971
mi
from 98109
Nashville, TN
Pain Management Smartphone Application for Patients With Stage III-IV Head and Neck Cancer Undergoing Radiation Therapy
A Pilot Study for a Pain Management Smartphone Application for Patients Undergoing Radiation Therapy for Locally Advanced Head and Neck Cancer
Status: Enrolling
Updated: 7/12/2016
Vanderbilt-Ingram Cancer Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1544
mi
from 98109
Cedar Rapids, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
1544
mi
from 98109
Cedar Rapids, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1463
mi
from 98109
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1463
mi
from 98109
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1462
mi
from 98109
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
1462
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1463
mi
from 98109
Des Moines, IA
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Iowa Lutheran Hospital
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated:  7/12/2016
1363
mi
from 98109
Papillion, NE
Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
PHASE III STUDY OF HEPATIC ARTERY FLOXURIDINE (FUDR), LEUCOVORIN (LV), AND DEXAMETHASONE (DEX) VERSUS SYSTEMIC 5-FLUOROURACIL (5-FU) AND LEUCOVORIN (LV) AS TREATMENT FOR HEPATIC METASTASES FROM COLORECTAL CANCER
Status: Enrolling
Updated: 7/12/2016
Midlands Cancer Center at Midlands Community Hospital
1363
mi
from 98109
Papillion, NE
Click here to add this to my saved trials